Technical Description
A formulation of silver containing bioactive glass. It provides an intravenous formulation of silver containing bioactive glass for action against cerebral ischemic reperfusion injury.
Problems Addressed
- High Ischemic Stroke Rates
- Antiplatelet Deficiency
- Limited Stroke Treatments
- Neurological dysfunction
Tech Features
- Antiplatelet Property
- Intravenous Bio-Glass
- AgBG Formulation
- Ischemic Injury Defense
- Cerebral Ischemia Treatment
Target Audience
- Medical Devices Industry
- Healthcare Sector
- Biomedical Sector
- Pharmaceutical Industry
- Materials Science Sector
- Biotechnology Sector
Tech ID: P06-1127 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
